Grant: Engage Plus Grants Program
University of Calgary
$12,500.00
Applying split TreA technology to detect antigen-specific antibodies in colostrum
FY 2018-19
Summary
Maternal antibodies are crucial in the protection of calves against a large number of neonatal diseases. In cattle,*maternal transfer of antibodies is restricted to the uptake of colostrum in contrast to other animals that are*capable of placental transfer. Consequently, the concentrations of antibodies in colostrum is essential for the*survival and well-being of the calves. Dairy producers have a choice of testing and storing high quality*colostrum on farm or purchasing commercially available (e.g. Saskatoon Colostrum Company Ltd. (SCCL))*quality controlled freeze dried colostrum. In a previous Engage project, we validated a novel technology for*testing total IgG in colostrum and serum samples for use in SCCL's quality control lab.*To protect calves from pathogens that threaten their health, such as those associated with scours and respiratory*disease, the levels of pathogen-specific antibodies are equally important as the total amount. Currently, to*determine the range and protective levels of these pathogen-specific antibodies in colostrum, SCCL needs to*collaborate with an external lab to run ELISAs.*In this project, we will adapt the technology previously used for total IgG detection to also quantify*pathogen-specific antibodies in colostrum. This technology is based on a split enzyme fused to pathogen*specific protein antigens. It has the advantage that no rinsing steps are required and that it can be customized to*include antigens of different pathogens.*The specific objectives of this project are: 1. Incorporation of pathogen-specific antigens in our bioreagents. 2.*Improvement and assay validation on blinded panels of colostrum pretested with ELISAs.*This project will assess the feasibility of detecting pathogen-specific antibodies in colostrum with a novel*technology and it will result in tests readily available for use by SCCL. These tests will allow SCCL to use*specific antibody testing results for premium labeling of their product and give the company marketing*advantages over competitors.
Program
Engage Plus Grants Program
Recipient
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
530497-2018
Name nom
DeBuck, Jeroen
Department département
Veterinary Medicine, Faculty of
Organization id
11
Institution établissement
University of Calgary
Province en
Alberta
Province fr
Alberta
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2018
Competition year année de concours
2018
Award amount
12500
Program id
EGP2
Program name en
Engage Plus Grants Program
Program name fr
Programme de subvention d'engagement partenarial Plus
Group en
Research partnerships programs
Group fr
Programmes de partenariat
Committee code
1555
Committee name en
Prairie Internal Decision Committee
Committee name fr
Comité de décision interne pour les Prairies
Area of application code
101
Area of application group en
Agriculture and primary food production
Area of application group fr
Agriculture et produits alimentaires primaires
Area of application en
Animal production and animal primary products
Area of application fr
Production animale et produits animaux primaires
Research subject code
5512
Research subject group en
Animal biology
Research subject group fr
Biologie animale
Research subject en
Veterinary sciences
Research subject fr
Médecine vétérinaire
Partie
1
Nb partie
1
Application title
Applying split TreA technology to detect antigen-specific antibodies in colostrum
Keyword
NSERC
Application summary
Maternal antibodies are crucial in the protection of calves against a large number of neonatal diseases. In cattle,*maternal transfer of antibodies is restricted to the uptake of colostrum in contrast to other animals that are*capable of placental transfer. Consequently, the concentrations of antibodies in colostrum is essential for the*survival and well-being of the calves. Dairy producers have a choice of testing and storing high quality*colostrum on farm or purchasing commercially available (e.g. Saskatoon Colostrum Company Ltd. (SCCL))*quality controlled freeze dried colostrum. In a previous Engage project, we validated a novel technology for*testing total IgG in colostrum and serum samples for use in SCCL's quality control lab.*To protect calves from pathogens that threaten their health, such as those associated with scours and respiratory*disease, the levels of pathogen-specific antibodies are equally important as the total amount. Currently, to*determine the range and protective levels of these pathogen-specific antibodies in colostrum, SCCL needs to*collaborate with an external lab to run ELISAs.*In this project, we will adapt the technology previously used for total IgG detection to also quantify*pathogen-specific antibodies in colostrum. This technology is based on a split enzyme fused to pathogen*specific protein antigens. It has the advantage that no rinsing steps are required and that it can be customized to*include antigens of different pathogens.*The specific objectives of this project are: 1. Incorporation of pathogen-specific antigens in our bioreagents. 2.*Improvement and assay validation on blinded panels of colostrum pretested with ELISAs.*This project will assess the feasibility of detecting pathogen-specific antibodies in colostrum with a novel*technology and it will result in tests readily available for use by SCCL. These tests will allow SCCL to use*specific antibody testing results for premium labeling of their product and give the company marketing*advantages over competitors.